119 related articles for article (PubMed ID: 25767303)
1. Global differential expression of genes located in the Down Syndrome Critical Region in normal human brain.
Montoya JC; Fajardo D; Peña A; Sánchez A; Domínguez MC; Satizábal JM; García-Vallejo F
Colomb Med (Cali); 2014; 45(4):154-61. PubMed ID: 25767303
[TBL] [Abstract][Full Text] [Related]
2. A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions.
Rachidi M; Delezoide AL; Delabar JM; Lopes C
Int J Dev Neurosci; 2009 Jun; 27(4):393-8. PubMed ID: 19460634
[TBL] [Abstract][Full Text] [Related]
3. Isolation of two novel genes, DSCR5 and DSCR6, from Down syndrome critical region on human chromosome 21q22.2.
Shibuya K; Kudoh J; Minoshima S; Kawasaki K; Asakawa S; Shimizu N
Biochem Biophys Res Commun; 2000 May; 271(3):693-8. PubMed ID: 10814524
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in the adult Down syndrome brain.
Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated?
Minami T
J Biochem; 2014 Apr; 155(4):217-26. PubMed ID: 24505143
[TBL] [Abstract][Full Text] [Related]
6. Inverse Comorbidity between Down Syndrome and Solid Tumors: Insights from In Silico Analyses of Down Syndrome Critical Region Genes.
Fosu K; Quarshie JT; Sarpong KAN; Aikins AR
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107558
[TBL] [Abstract][Full Text] [Related]
7. Pattern of TAAR5 Expression in the Human Brain Based on Transcriptome Datasets Analysis.
Vaganova AN; Murtazina RZ; Shemyakova TS; Prjibelski AD; Katolikova NV; Gainetdinov RR
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445502
[TBL] [Abstract][Full Text] [Related]
8. Integrated Quantitative Neuro-Transcriptome Analysis of Several Brain Areas in Human Trisomy 21.
Rodríguez-Ortiz A; Montoya-Villegas JC; García-Vallejo F; Mina-Paz Y
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456434
[TBL] [Abstract][Full Text] [Related]
9. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of a gene expressed in mouse developing tongue, mDscr5 gene, a homolog of human DSCR5 (Down syndrome Critical Region gene 5).
Choi DK; Suzuki Y; Yoshimura S; Togashi T; Hida M; Taylor TD; Wang Y; Sugano S; Hattori M; Sakaki Y
Mamm Genome; 2001 May; 12(5):347-51. PubMed ID: 11331941
[TBL] [Abstract][Full Text] [Related]
11. Screening of human chromosome 21 genes in the dorsolateral prefrontal cortex of individuals with Down syndrome.
Kong XD; Liu N; Xu XJ; Zhao ZH; Jiang M
Mol Med Rep; 2015 Feb; 11(2):1235-9. PubMed ID: 25370074
[TBL] [Abstract][Full Text] [Related]
12. Down syndrome critical region gene 2: expression during mouse development and in human cell lines indicates a function related to cell proliferation.
Vidal-Taboada JM; Lu A; Pique M; Pons G; Gil J; Oliva R
Biochem Biophys Res Commun; 2000 May; 272(1):156-63. PubMed ID: 10872820
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the human holocarboxylase synthetase gene (HCS) to the Down syndrome critical region of chromosome 21q22.
Blouin JL; Duriaux Saïl G; Antonarakis SE
Ann Genet; 1996; 39(3):185-8. PubMed ID: 8839893
[TBL] [Abstract][Full Text] [Related]
14. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
[TBL] [Abstract][Full Text] [Related]
15. PCP4 (PEP19) overexpression induces premature neuronal differentiation associated with Ca(2+) /calmodulin-dependent kinase II-δ activation in mouse models of Down syndrome.
Mouton-Liger F; Thomas S; Rattenbach R; Magnol L; Larigaldie V; Ledru A; Herault Y; Verney C; Créau N
J Comp Neurol; 2011 Oct; 519(14):2779-802. PubMed ID: 21491429
[TBL] [Abstract][Full Text] [Related]
16. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms.
Rachidi M; Lopes C
Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742
[TBL] [Abstract][Full Text] [Related]
17. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
[TBL] [Abstract][Full Text] [Related]
18. [Detecting Down syndrome with a novel dual-color competitive quantitative fluorescent polymerase chain reaction method].
Wu P; Li QJ; Xia ZL; Zhang FQ; Yue LL; Chen QY; Wang H; Fan CY; Xia QJ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):43-7. PubMed ID: 22311490
[TBL] [Abstract][Full Text] [Related]
19. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways.
Rachidi M; Lopes C
Eur J Paediatr Neurol; 2008 May; 12(3):168-82. PubMed ID: 17933568
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region".
Song WJ; Sternberg LR; Kasten-Sportès C; Keuren ML; Chung SH; Slack AC; Miller DE; Glover TW; Chiang PW; Lou L; Kurnit DM
Genomics; 1996 Dec; 38(3):331-9. PubMed ID: 8975710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
